PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2017 October; 8(4): e0040. ISSN: 2076-9172Published online 2017 October 16. doi: 10.5041/RMMJ.10314.

Table 1.

Commercially Available Urine-based Tumor Markers.

Marker Type	Test	Manufacturer
Protein-based	NMP22 NMP22 BladderChek	Alere, Waltham, MA, USA
	BTA TRAK BTA STAT	Polymedco, Cortlandt Manor, NY, USA
Cytologic immunohistochemistry	uCyt+ (Immunocyt)	Scimedx Inc., Denville, NJ, USA
Genetic-based	UroVysion FISH	Abbott Inc., Abbott Park, IL, USA
	Cxbladder	Pacific Edge Inc., Dunedin, New Zealand

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2017 October; 8(4): e0040. ISSN: 2076-9172

Published online 2017 October 16. doi: 10.5041/RMMJ.10314